Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen for bleeding prevention in CABG
NCT00968045Phase 2Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Apr 2009
- Primary completion
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Fibrinogen human in postoperative hemorrhage, sponsored by Sahlgrenska University Hospital. Started Apr 2009; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT00968045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00968045.